Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01C HYPOTHALAMIC HORMONES
H01CC Anti-gonadotropin-releasing hormones
H01CC03 Elagolix
D09336 Elagolix sodium (USAN) <US>
USP drug classification [BR:br08302]
Hormonal Agents, Suppressant (Pituitary)
Elagolix
D09336 Elagolix sodium (USAN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Gonadotropin-releasing hormone
GNRHR
D09336 Elagolix sodium (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09336
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09336
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D09336